Insider · CIK 0001579887
Backenroth Samuel
Reports to the SEC for 2 companies · NEW YORK, NY
Transactions
32
Companies
2
Filings
8
CIK
0001579887
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-03-31 | Notable Labs, Ltd.M Exercise/Conversion | — |
| 2023-03-31 | Notable Labs, Ltd.Restricted Stock UnitsM Exercise/Conversion | — |
| 2020-12-29 | NeuBase Therapeutics, Inc.Stock option (right to buy)A Award | — |
| 2020-04-30 | NeuBase Therapeutics, Inc.P Purchase | +$6,000 |
| 2019-07-12 | NeuBase Therapeutics, Inc.Employee stock option (right to buy)J Other | — |
| 2019-07-12 | NeuBase Therapeutics, Inc.Employee stock option (right to buy)A Award | — |
| 2017-10-16 | NeuBase Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2017-04-10 | NeuBase Therapeutics, Inc.P Purchase | +$50K |
| 2017-04-10 | NeuBase Therapeutics, Inc.Warrants (right to buy)P Purchase | — |
| 2016-06-20 | NeuBase Therapeutics, Inc.P Purchase | +$1,291.5 |
| 2016-06-20 | NeuBase Therapeutics, Inc.P Purchase | +$28.9 |
| 2016-06-20 | NeuBase Therapeutics, Inc.P Purchase | +$542 |
| 2016-06-20 | NeuBase Therapeutics, Inc.P Purchase | +$23.04 |
| 2016-06-20 | NeuBase Therapeutics, Inc.P Purchase | +$5,112 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$484.88 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$526.49 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$35.42 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$590.64 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$172.8 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$610.56 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$2,643.78 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$1,197.64 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$579.6 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$135.02 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$303.61 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$34.375 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$508.56 |
| 2016-05-23 | NeuBase Therapeutics, Inc.P Purchase | +$102.63 |
| 2016-01-07 | NeuBase Therapeutics, Inc.A Award | — |
| 2015-03-10 | NeuBase Therapeutics, Inc.OptionA Award | — |
| 2015-02-06 | NeuBase Therapeutics, Inc.P Purchase | +$10.1K |
| 2014-02-03 | NeuBase Therapeutics, Inc.OptionA Award | — |
Recent filings
- 4Backenroth Samuel0001493152-23-012789SEC(opens sec.gov)
- 4Backenroth Samuel0001104659-20-140594SEC(opens sec.gov)
- 4Backenroth Samuel0001104659-20-056066SEC(opens sec.gov)
- 4Backenroth Samuel0001387131-19-005128SEC(opens sec.gov)
- 4Backenroth Samuel0001387131-17-005090SEC(opens sec.gov)
- 4Ohr Pharmaceutical Inc0001387131-17-002049SEC(opens sec.gov)
- 4Ohr Pharmaceutical Inc0001387131-16-005871SEC(opens sec.gov)
- 4Ohr Pharmaceutical Inc0001387131-16-005678SEC(opens sec.gov)
Companies
Address
489 5TH AVE., 28TH FLOOR
NEW YORK, NY, 10017